Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
June 26, 2009
Design and construction of synthetic phage-displayed Fab libraries
Jenny Bostrom, Germaine Fuh
Methods in Molecular Biology (Clifton, N.J.)
|
March 3, 2009
Improving antibody binding affinity and specificity for therapeutic development
Jenny Bostrom, Chingwei V Lee, Lauric Haber, et al.
Plos One
|
April 29, 2011
High affinity antigen recognition of the dual specific variants of herceptin is entropy-driven in spite of structural plasticity
Jenny Bostrom, Lauric Haber, Patrick Koenig, et al.
Plos One
|
May 8, 2012
Translation levels control multi-spanning membrane protein expression
Hok Seon Kim, James A Ernst, Cecilia Brown, et al.
Science (New York, N.Y.)
|
March 21, 2009
Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site
Jenny Bostrom, Shang-Fan Yu, David Kan, et al.
Cancer Cell
|
October 22, 2011
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies
Gabriele Schaefer, Lauric Haber, Lisa M Crocker, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Methods in Molecular Biology (Clifton, N.J.)
|
June 26, 2009
Design and construction of synthetic phage-displayed Fab libraries
Jenny Bostrom, Germaine Fuh
Methods in Molecular Biology (Clifton, N.J.)
|
March 3, 2009
Improving antibody binding affinity and specificity for therapeutic development
Jenny Bostrom, Chingwei V Lee, Lauric Haber, et al.
Plos One
|
April 29, 2011
High affinity antigen recognition of the dual specific variants of herceptin is entropy-driven in spite of structural plasticity
Jenny Bostrom, Lauric Haber, Patrick Koenig, et al.
Plos One
|
May 8, 2012
Translation levels control multi-spanning membrane protein expression
Hok Seon Kim, James A Ernst, Cecilia Brown, et al.
Science (New York, N.Y.)
|
March 21, 2009
Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site
Jenny Bostrom, Shang-Fan Yu, David Kan, et al.
Cancer Cell
|
October 22, 2011
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies
Gabriele Schaefer, Lauric Haber, Lisa M Crocker, et al.
Page
of 1